Liabilities / Assets
91st percentile
Higher debt load relative to assets than 91% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
91st percentile
Higher debt load relative to assets than 91% of similar nonprofits.
Liabilities / Revenue
97th percentile
Higher debt load relative to revenue than 97% of similar nonprofits.
Net Margin
4th percentile
Higher net margin than 4% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
16th percentile
Faster asset growth than 16% of similar nonprofits.
Revenue Growth
4th percentile
Faster revenue growth than 4% of similar nonprofits.
Assets
Down$359,894
Down $142,372 (-28%) from 2016
Net Assets
Down$131,778
Down $212,297 (-62%) from 2016
Liabilities
Up$228,116
Up $69,925 (+44%) from 2016
Revenue
Down$157,001
Down $596,482 (-79%) from 2016
Expenses
Down$359,298
Down $8,508 (-2.3%) from 2016
Net Income
Down-$202,297
Down $587,974 (-152%) from 2016
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Supports organizations and initiatives that improve the availability of vaccines, medicines and other healthcare products to those in need worldwide through a variety of educational and charitable activities, including those focused on pharmaceutical supply chain improvements.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.